The prognostic role of tumor-infiltrating lymphocytes after treatment with neo-adjuvant chemotherapy in inflammatory breast cancer patients

被引:0
|
作者
Van Berckelaer, Christophe [1 ,2 ]
Vercauteren, Leonie [3 ]
Vermeiren, Iris [3 ]
Broeckx, Glenn [4 ]
Van Laere, Steven [1 ,2 ]
Dirix, Luc [1 ,2 ]
Colpaert, Cecile [4 ]
Van Dam, Peter [3 ]
机构
[1] Univ Antwerp, GZA Hosp, Translat Canc Res Unit, Antwerp, Belgium
[2] Univ Antwerp, CORE, Antwerp, Belgium
[3] Antwerp Univ Hosp UZA, Multidisciplinary Breast Clin, Unit Gynaecol Oncol, Edegem, Belgium
[4] Antwerp Univ Hosp UZA, Dept Pathol, Edegem, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS17-13
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).
    Luen, Stephen James
    Salgado, Roberto
    Dieci, Maria Vittoria
    Vingiani, Andrea
    Curigliano, Giuseppe
    Hubbard, Rebekah
    Altamirano, Carlos Castaneda
    Sanchez, Joselyn
    D'Alfonso, Timothy
    Cheng, Esther
    Garcia, Miluska Castillo
    Adams, Sylvia
    Ahmed, Fahad
    Rimm, David L.
    Demaria, Sandra
    Symmans, William Fraser
    Michiels, Stefan
    Loi, Sherene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Management of inflammatory breast cancer after neo-adjuvant chemotherapy
    Abrous-Anane, S.
    Savignoni, A.
    Daveau, C.
    Pierga, J. -Y.
    Gautier, C.
    Reyal, F.
    Dendale, R.
    Campana, F.
    Kirova, Y.
    Fourquet, A.
    Bollet, M. -A.
    [J]. CANCER RADIOTHERAPIE, 2011, 15 (08): : 654 - 662
  • [3] The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
    A. J. Eustace
    S. F. Madden
    J. Fay
    D. M. Collins
    E. W. Kay
    K. M. Sheehan
    S. Furney
    B. Moran
    A. Fagan
    P. G. Morris
    A. Teiserskiene
    A. D. Hill
    L. Grogan
    J. M. Walshe
    O. Breathnach
    C. Power
    D. Duke
    K. Egan
    W. M. Gallagher
    N. O’Donovan
    J. Crown
    S. Toomey
    B. T. Hennessy
    [J]. Breast Cancer Research and Treatment, 2021, 187 : 635 - 645
  • [4] The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
    Eustace, A. J.
    Madden, S. F.
    Fay, J.
    Collins, D. M.
    Kay, E. W.
    Sheehan, K. M.
    Furney, S.
    Moran, B.
    Fagan, A.
    Morris, P. G.
    Teiserskiene, A.
    Hill, A. D.
    Grogan, L.
    Walshe, J. M.
    Breathnach, O.
    Power, C.
    Duke, D.
    Egan, K.
    Gallagher, W. M.
    O'Donovan, N.
    Crown, J.
    Toomey, S.
    Hennessy, B. T.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (03) : 635 - 645
  • [5] Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy
    Mozarowski, Paul
    Rasaiah, Bhubendra
    Reed, Melissa
    Lewis, Alexis
    Walde, Natalie
    Voutsadakis, Ioannis A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 10
  • [6] Tumor-infiltrating lymphocytes (TILs) for prediction of response to platinum-based neo-adjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC)
    Abdullaeva, Sheyda
    Semiglazova, Tatiana
    Artemyeva, Anna
    Semiglazov, Vladislav
    Krivorotko, Petr
    Semiglazov, Vladimir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] The role of tumor-infiltrating lymphocytes, prognostic and predictive signification in breast cancer
    Tseluiko, A.
    Semiglazov, V.
    Kudaibergenova, A.
    Urezkova, M.
    Artemieva, A.
    Krivorotko, P.
    [J]. BREAST, 2021, 56 : S65 - S65
  • [8] The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer
    Ilgun, Ahmet Serkan
    Aktepe, Fatma
    Gonullu, Onur
    Kapucuoglu, Nilgun
    Yararbas, Kanay
    Alco, Gul
    Ozturk, Alper
    Celebi, Filiz Elbuken
    Erdogan, Zeynep
    Ordu, Cetin
    Unal, Caglar
    Duymaz, Tomris
    Soybir, Gursel
    Yavuz, Ekrem
    Tuzlali, Sitki
    Ozmen, Vahit
    [J]. FUTURE ONCOLOGY, 2022, 18 (29) : 3289 - 3298
  • [9] Differential expressions of immune check point receptors on tumor infiltrating lymphocytes after neo-adjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC)
    Abbasov, Ayxan
    Cetin, Esin
    Cabioglu, Neslihan
    Mollavelioglu, Baran
    Onder, Semen
    Emiroglu, Selman
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Deniz, Gunnur
    Ozmen, Vahit
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [10] Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy
    Demaria, S
    Volm, MD
    Shapiro, RL
    Yee, HT
    Oratz, R
    Formenti, SC
    Muggia, F
    Symmans, WF
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (10) : 3025 - 3030